(SGEN) Seattle Genetics’ Adcetris under FDA Review
Seattle Genetics, Inc. (SGEN) recently announced that the US Food and Drug Administration (FDA) has accepted its supplemental biologics license application (sBLA) seeking approval of Adcetris...
View Article(SGEN) Seattle Genetics Starts SGN-CD19A Phase I Study
Seattle Genetics Inc. (SGEN) recently commenced two phase I clinical studies with its oncology candidate, SGN-CD19A. The two trials will assess the safety and anti-tumor response of SGN-CD19A in...
View Article(SGEN) Seattle Genetics’ Adcetris Earns Approval from Health Canada
Seattle Genetics Inc. (SGEN) recently received approval from Health Canada for its oncology drug, Adcetris (brentuximab vedotin). Adcetris has been approved under Health Canada’s Notice of Compliance...
View Article(ABX) Why Gold Mining Stocks Are About to Skyrocket
by Dr. Mark Skousen, Investment U Contributing Editor Wednesday, September 21, 2011: Issue #1605 Are you frustrated by the failure of gold mining stocks to keep up with gold? I am. While gold and...
View Article(AAPL) Company News for May 10, 2011 – Corporate Summary
• Hospitality Properties (NYSE:HPT) reported Q1 FFO of $0.83, topping the Zacks Consensus Estimate of $0.81 per share by 2 cents. Revenues for the quarter rose 10.9% year-over-year to $281.9...
View Article(SLV) Seven Reasons A Boom in Silver is Beginning
Joe Kunkle, The Investment U Research Team With gold and oil hogging the “commodities spotlight,” silver is too often forgotten. However, a new trend is emerging that indicates a major rally may be...
View Article
/pic9814888.png)
/fit-in/580x348/filters:format(webp)/english-betterindia/media/media_files/2026/09/17/balaghat-3-2026-09-17-18-46-40.png)